Showing 1601-1610 of 1635 results for "".
- Aerie Announces US Launch of Rhopressahttps://modernod.com/news/aerie-announces-us-launch-of-rhopressa/2480197/Aerie Pharmaceuticals announced that it has launched Rhopressa in the United States. Rhopressa is now in national and regional US pharmaceutical distributors, and patients have access to Rhopressa through their local pharmacies across the nation. “We are pleased to announce the availabilit
- USC Roski Eye Institute Scientists Present Latest Research at the ARVO Annual Meetinghttps://modernod.com/news/usc-roski-eye-institute-scientists-present-latest-research-at-the-arvo-annual-meeting/2480198/What do nanophotoswitches, lipid nanoparticles, and mapping the brain have in common? They are among the future-forward areas of vision research being investigated by USC Roski Eye Institute
- Novartis Confirms 2018 Targets as Alcon Recovery Gains Steamhttps://modernod.com/news/novartis-confirms-2018-targets-as-alcon-recovery-gains-steam/2480224/Swiss drugmaker Novartis’ first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit, according to a
- Study Shows No Benefit From Fatty Acid Supplements in Dry Eyehttps://modernod.com/news/study-shows-no-benefit-from-fatty-acid-supplements-in-dry-eye/2480241/A clinical trial supported by the National Eye Institute shows that oral omega-3 is no better than placebo in relieving signs and symptoms of dry eye disease. The Dry Eye and Assessment Management Study (DREAM) is the first large-scale real-world, double-masked, randomized clinical trial t
- Allergan Announces Official Launch of the TrueTear Intranasal Neurostimulation Devicehttps://modernod.com/news/allergan-announces-launch-of-the-truetear-intranasal-neurostimulation-device-at-ascrs/2480250/Allergan announced the official launch of TrueTear, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients. TrueTear, a handheld neurostimulation device with disposable tips that is inserted into the nasal cavity to
- Dallas Lighthouse for the Blind to Merge With Envisionhttps://modernod.com/news/dallas-lighthouse-for-the-blind-to-merge-with-envision/2480267/Envision announced that it has acquired the Dallas Lighthouse for the Blind. Operations will continue as normal in Dallas, and the Dallas Lighthouse for the Blind name will be retained. Financial terms of the deal were not disclosed. The merger will have positive benefits both in Te
- Global Dry Eye Treatment Revenues to Grow to $4.9 Billion by 2022https://modernod.com/news/global-dry-eye-treatment-revenues-to-grow-to-49-billion-by-2022/2480272/Market Scope expects the global dry eye treatments market to grow at a healthy pace through 2022, as 2017 revenues of $3.7 billion climb to $4.9 billion. Revenues will climb most sharply in emerging markets and other developing nations where we forecast double-digit compounded annual growth rates
- Chi Na Mouahttps://modernod.com/profiles/chi-na-moua/Lze60b/
- Nazneen Aziz, PhDhttps://modernod.com/profiles/nazneen-aziz-phd/OXN1p1/
- Naureen M. Haroon, OD, MPH, FAAOhttps://modernod.com/profiles/naureen-m-haroon-od-mph-faao/OBB1nr/